Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

BIO CAPITAL : revenue, balance sheet and financial ratios

BIO CAPITAL is a French company founded 7 years ago, specialized in the sector Fonds de placement et entités financières similaires. Based in PARIS (75016), this company of category PME shows in 2020 a net income negative of -354 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - BIO CAPITAL (SIREN 841269095)
Indicator 2020 2019
Revenue N/C N/C
Net income -353 840 € -657 €
EBITDA -141 € N/C
Net margin N/C N/C

Revenue and income statement

In 2020, BIO CAPITAL records a net loss of 354 k€. This deficit will reduce equity on the balance sheet.

EBITDA (2020) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-141 €

EBIT (2020) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-141 €

Net income (2020) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-353 840 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at -111%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -882%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2020) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

-111.34%

Financial autonomy (2020) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

-881.818%

Repayment capacity (2020) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

-0.766

Solvency indicators evolution
BIO CAPITAL

Sector positioning

Debt ratio
-111.34 2020
2019
2020
Q1: 0.01
Med: 10.43
Q3: 82.59
Excellent

In 2020, the debt ratio of BIO CAPITAL (-111.34) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
-881.82% 2020
2019
2020
Q1: 16.33%
Med: 62.48%
Q3: 90.92%
Average -50 pts over 2 years

In 2020, the financial autonomy of BIO CAPITAL (-881.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
-0.77 years 2020
2020
Q1: -0.03 years
Med: 0.01 years
Q3: 3.79 years
Excellent

In 2020, the repayment capacity of BIO CAPITAL (-0.77) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

Interest coverage (2020) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-250850.355

Liquidity indicators evolution
BIO CAPITAL

Sector positioning

Interest coverage
-250850.36x 2020
2020
Q1: -63.5x
Med: 0.0x
Q3: 0.0x
Watch

In 2020, the interest coverage of BIO CAPITAL (-250850.4x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.

Positioning of BIO CAPITAL in its sector

Comparison with sector Fonds de placement et entités financières similaires

Similar companies (Fonds de placement et entités financières similaires)

Compare BIO CAPITAL with other companies in the same sector:

Frequently asked questions about BIO CAPITAL

What is the revenue of BIO CAPITAL ?

The revenue of BIO CAPITAL is not publicly disclosed (confidential accounts filed with INPI).

Is BIO CAPITAL profitable?

BIO CAPITAL recorded a net loss in 2020.

Where is the headquarters of BIO CAPITAL ?

The headquarters of BIO CAPITAL is located in PARIS (75016), in the department Paris.

Where to find the tax return of BIO CAPITAL ?

The tax return of BIO CAPITAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does BIO CAPITAL operate?

BIO CAPITAL operates in the sector Fonds de placement et entités financières similaires (NAF code 64.30Z). See the 'Sector positioning' section above to compare the company with its competitors.